Approach to a Patient with Progressive Cancer, Pain and Moderate OUD in Long-Term Remission - November 15, 2023
This site is for learners who attended the live November 15, 2023, program to claim credit.
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants
Upon completion of this activity, participants will be able to:
- Reassess pain in a cancer patient on pain medication.
- Screen for risk of adverse events including overdose or death.
- Assess risk versus benefit.
- Mitigate risk through harm reduction and basic problem solving.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.
ADA statement: To request reasonable accommodations for a disability please contact MCSTAP@beaconhealthoptions.com, in writing, at least two weeks prior to the activity.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation